Inovio Pharmaceuticals Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-03-11 17:35:46 ET
More on Inovio Pharmaceuticals
- Inovio Pharmaceuticals, Inc. (INO) Presents at The Citizens Life Sciences Conference 2026 Transcript
- Inovio Pharmaceuticals, Inc. (INO) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
- INO-3107 At The Crossroads: FDA Review Drives Inovio's Upside And Risk
- Inovio drops as respiratory papillomatosis asset denied accelerated review
- Seeking Alpha’s Quant Rating on Inovio Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Inovio Pharmaceuticals Q4 2025 Earnings Preview
Inovio Pharmaceuticals Inc.
NASDAQ: INO
INO Trading
-0.58% G/L:
$1.725 Last:
722,739 Volume:
$1.74 Open:
INO Latest News
March 10, 2026 09:00:00 am
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before April 7, 2026 to Discuss Your Rights - INO
March 05, 2026 04:05:00 pm
INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
March 04, 2026 08:05:00 am
INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
INO Stock Data
$114,678,989
66,160,955
0.88%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
Plymouth Meeting
